Pei-Lan He Selected Research

SM905

6/2007

Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pei-Lan He Research Topics

Disease

6	Hypersensitivity (Allergy) 12/2009 - 05/2005
2	Inflammation (Inflammations) 10/2018 - 01/2012
2	Influenza in Birds (Avian Flu) 08/2012 - 10/2006
2	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 08/2011
2	Immune System Diseases (Immune Disorders) 06/2007 - 05/2006
1	Body Weight (Weight, Body) 10/2018
1	Colitis 10/2018
1	Ulcerative Colitis 10/2018
1	Chronic Hepatitis B 01/2016
1	Infections 08/2012
1	Glomerulonephritis 01/2012
1	Proteinuria 08/2011
1	Arthritis (Polyarthritis) 07/2006
1	Experimental Arthritis 07/2006
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2006
1	Hepatitis 05/2006

Drug/Important Bio-Agent (IBA)

4	beta-aminoarteether maleateIBA 10/2018 - 12/2009
2	artemisinin (artemisinine)IBA 10/2018 - 01/2012
2	Zanamivir (Relenza)FDA Link 08/2012 - 10/2006
2	Interferon-gamma (Interferon, gamma)IBA 06/2007 - 07/2006
2	Concanavalin AIBA 06/2007 - 05/2006
2	DinitrofluorobenzeneIBA 12/2005 - 07/2005
1	Dextran SulfateIBA 10/2018
1	Urea (Carbamide)FDA LinkGeneric 08/2011
1	AntibodiesIBA 08/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	NitrogenIBA 08/2011
1	SM905IBA 06/2007
1	InterleukinsIBA 06/2007
1	CollagenIBA 07/2006
1	triptolideIBA 06/2006
1	CytokinesIBA 05/2006
1	OvalbuminIBA 02/2006
1	AntigensIBA 02/2006
1	methyl 4-(adenin-9-yl)-2-hydroxybutanoateIBA 05/2005

Therapy/Procedure

1	Oral Administration 10/2018
1	Therapeutics 01/2016